BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17005399)

  • 1. Myopathy in horses with pituitary pars intermedia dysfunction (Cushing's disease).
    Aleman M; Watson JL; Williams DC; LeCouteur RA; Nieto JE; Shelton GD
    Neuromuscul Disord; 2006 Nov; 16(11):737-44. PubMed ID: 17005399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcoplasmic masses in equine skeletal muscle.
    Aleman M; Lecouteur RA; Nieto JE; Williams DC; Stanke NJ; Shelton GD
    Neuromuscul Disord; 2005 Feb; 15(2):147-53. PubMed ID: 15694136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of proteolytic systems and growth regulators of skeletal muscle in horses with myopathy associated with pituitary pars intermedia dysfunction.
    Aleman M; Nieto JE
    Am J Vet Res; 2010 Jun; 71(6):664-70. PubMed ID: 20513182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PITUITARY PARS INTERMEDIA DYSFUNCTION (EQUINE CUSHING'S DISEASE) IN NONDOMESTIC EQUIDS AT MARWELL WILDLIFE: A CASE SERIES. ONE CHAPMAN'S ZEBRA ( EQUUS QUAGGA CHAPMANI) AND FIVE PRZEWALSKI's HORSES ( EQUUS FERUS PRZEWALSKII).
    Shotton JCR; Justice WSM; Salguero FJ; Stevens A; Bacci B
    J Zoo Wildl Med; 2018 Jun; 49(2):404-411. PubMed ID: 29900762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction.
    McFarlane D; Dybdal N; Donaldson MT; Miller L; Cribb AE
    J Neuroendocrinol; 2005 Feb; 17(2):73-80. PubMed ID: 15796757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of polysaccharide storage myopathy: necropsy study of 225 horses.
    Valentine BA; Cooper BJ
    Vet Pathol; 2005 Nov; 42(6):823-7. PubMed ID: 16301580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denervation atrophy in three horses with fibrotic myopathy.
    Valentine BA; Rousselle SD; Sams AE; Edwards RB 3drd
    J Am Vet Med Assoc; 1994 Jul; 205(2):332-6. PubMed ID: 7928615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the skeletal muscle phenotype of equine motor neuron disease: a quantitative approach.
    Palencia P; Quiroz-Rothe E; Rivero JL
    Acta Neuropathol; 2005 Mar; 109(3):272-84. PubMed ID: 15616793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epidemiological study of myopathies in Warmblood horses.
    Hunt LM; Valberg SJ; Steffenhagen K; McCue ME
    Equine Vet J; 2008 Mar; 40(2):171-7. PubMed ID: 18089471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polysaccharide storage myopathy in Cob Normand draft horses.
    Larcher T; Herszberg B; Molon-Noblot S; Guigand L; Chaffaux S; Guerin G; Cherel Y
    Vet Pathol; 2008 Mar; 45(2):154-8. PubMed ID: 18424827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial alterations in muscle biopsies of patients on statin therapy.
    Gambelli S; Dotti MT; Malandrini A; Mondelli M; Stromillo ML; Gaudiano C; Federico A
    J Submicrosc Cytol Pathol; 2004 Jan; 36(1):85-9. PubMed ID: 15311678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J; Boston R; Lindborg S; Russell GE
    J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine pituitary pars intermedia dysfunction.
    McFarlane D
    Vet Clin North Am Equine Pract; 2011 Apr; 27(1):93-113. PubMed ID: 21392656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe polysaccharide storage myopathy in Belgian and Percheron draught horses.
    Valentine BA; Credille KM; Lavoie JP; Fatone S; Guard C; Cummings JF; Cooper BJ
    Equine Vet J; 1997 May; 29(3):220-5. PubMed ID: 9234015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalences and clinical signs of polysaccharide storage myopathy and shivers in Belgian draft horses.
    Firshman AM; Baird JD; Valberg SJ
    J Am Vet Med Assoc; 2005 Dec; 227(12):1958-64. PubMed ID: 16379634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical and myopathological features of oculopharyngodistal myopathy in a Chinese family.
    Lu H; Luan X; Yuan Y; Dong M; Sun W; Yan C
    Neuropathology; 2008 Dec; 28(6):599-603. PubMed ID: 18503509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction.
    Miller MA; Pardo ID; Jackson LP; Moore GE; Sojka JE
    Vet Pathol; 2008 Jan; 45(1):26-38. PubMed ID: 18192571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suspensory ligament degeneration associated with pituitary pars intermedia dysfunction in horses.
    Hofberger S; Gauff F; Licka T
    Vet J; 2015 Mar; 203(3):348-50. PubMed ID: 25641552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses.
    Lee ZY; Zylstra R; Haritou SJ
    Vet J; 2010 Jul; 185(1):58-61. PubMed ID: 20537574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic testing for pituitary pars intermedia dysfunction in horses.
    Dybdal NO; Hargreaves KM; Madigan JE; Gribble DH; Kennedy PC; Stabenfeldt GH
    J Am Vet Med Assoc; 1994 Feb; 204(4):627-32. PubMed ID: 8163420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.